PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-09-01

Date Title Company
01-Sep-2020 PAI Awarded HealthTrust Purchasing Group Contract Pharmaceutical Associates, Inc.
01-Sep-2020 Humoral immune response to SARS-CoV2 in Iceland deCODE genetics
01-Sep-2020 Humoral immune response to SARS-CoV2 in Iceland deCODE genetics
01-Sep-2020 Humoral immune response to SARS-CoV2 in Iceland deCODE genetics
01-Sep-2020 Muckle-Wells Syndrome Market Forecasts to 2027: 2020 Business Strategies and Leading Players are Regeneron, Novartis AG, Istituto Giannina Gaslini, Regeneron Pharmaceuticals, Inc., Charite-Universitatsmedizin Berlin CDN Newswire
01-Sep-2020 Laboratory Information Systems (LIS) Market 2020 Global Trend By Product Type, Device, Components, Delivery Mode and Top Leaders Sunquest Information Systems, Inc., Cerner Corporation, SSC Soft Computer, Compugroup Medical AG CDN Newswire
01-Sep-2020 Global Operational Room Management Market Next Big Thing | Major Giants Omnicell, Inc., Allscripts Healthcare Solutions, Inc., Getinge AB, Richard Wolf GmbH, Cerner Corp., Steris PLC, Nexus AG CDN Newswire
01-Sep-2020 Global Heart Pump Devices Market Surprising Growth due to Covid 19 include Major Players W. L. Gore & Associates, Inc., lepumedical.com, Getinge AB., Medtronic, Abbott, Boston Scientific Corporation CDN Newswire
01-Sep-2020 Sanofi to commence tender offer for acquisition of Principia Biopharma Inc. Sanofi
01-Sep-2020 Hard-to-treat pancreatic cancer hijacks immune system and could be targeted with immunotherapies The Institute of Cancer Research
01-Sep-2020 Empagliflozin (Jardiance®) meets primary endpoint in Phase III heart failure trial with and without diabetes Boehringer Ingelheim and Eli Lilly and Company (Lilly)
01-Sep-2020 SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics SOTIO
01-Sep-2020 Biocartis Expands Collaboration with LifeArc Biocartis Group NV
01-Sep-2020 Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Oxurion NV
01-Sep-2020 Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S. Sanofi
01-Sep-2020 Induction subsidiary Horizon achieves earn-out target ahead of schedule Induction Healthcare Group PLC
01-Sep-2020 Emergex Vaccines forms US subsidiary (Emergex USA) by acquisition of laboratories, technology and assets of US-based T cell specialist biotech ImmProNano Emergex Vaccines Holding Limited
01-Sep-2020 BioVersys Announces CHF 19 Million Financing to Advance Novel AMR Candidates into Clinical Development BioVersys
01-Sep-2020 Chromologics Announces Seed Round Led by Novo Holdings and Supported by Vækstfonden and Nordic FoodTech VC Chromologics
01-Sep-2020 Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Oxurion NV